medicine-news-1/duraheart-26amp-3b-238482-3b-third-generation-left-ventricular-assist-system-featured-at-23rd-annual-meeting-of-the-european-association-for-cardio-th-59434-1/;/a><br
| We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/duraheart-26amp-3b-238482-3b-third-generation-left-ventricular-assist-system-featured-at-23rd-annual-meeting-of-the-european-association-for-cardio-th-59434-1/;/a><br) was not found. Search medicine news 1 duraheart 26amp 3b 238482 3b third generation left ventricular assist system featured at 23rd annual meeting of the european association for cardio th 59434 1 ; a><br at Google Search medicine news 1 duraheart 26amp 3b 238482 3b third generation left ventricular assist system featured at 23rd annual meeting of the european association for cardio th 59434 1 ; a><br at Yahoo Search medicine news 1 duraheart 26amp 3b 238482 3b third generation left ventricular assist system featured at 23rd annual meeting of the european association for cardio th 59434 1 ; a><br at Msn |
Breaking Biology Technology:Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 2Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 3New technology could boost disease detection tests' speed and sensitivity 2Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2
[0] Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project[0] New technology could boost disease detection tests' speed and sensitivity[0] Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry[0] Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
Breaking Medicine Technology:Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5At Nearly $120 Million, The Hepatitis C Drug Market in Brazil is Among the Largest Emerging Pharmaceutical Markets for the Disease 2Study shows that elderly women sleep better than they think men sleep worse 58615 1Study shows that elderly women sleep better than they think men sleep worse 58615 2Platelet rich plasma 3A Does it work 3F 58610 1Platelet rich plasma 3A Does it work 3F 58610 2Platelet rich plasma 3A Does it work 3F 58610 3Announcing the new Journal of Integrated Pest Management 10201 1Announcing the new Journal of Integrated Pest Management 10201 2
[0] Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy[0] Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy[0] At Nearly $120 Million, The Hepatitis C Drug Market in Brazil is Among the Largest Emerging Pharmaceutical Markets for the Disease
| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |